ImmuniCell® in Patients With Advanced Cancers

NCT02459067 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma
Non-small Cell Lung Cancer
Renal Cell Cancer

Interventions

BIOLOGICAL: ImmuniCell®

Sponsor

TC Biopharm